# U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

> **NCT06069661** · NA · WITHDRAWN · sponsor: **EnCompass Technologies, Inc.**

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** Aortic Stenosis

## Key facts

- **NCT ID:** NCT06069661
- **Lead sponsor:** EnCompass Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-06
- **Primary completion:** 2024-12
- **Final completion:** 2025-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** moving directly into the Pivotal study
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069661, "U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06069661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*